Clinical Trial Update: Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

View source ↗

Summary

ClinicalTrials.gov update describing a pharmacogenetics study of anastrozole in postmenopausal women with ER/PR-positive breast cancer (stages I–III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Status: COMPLETED